UPDATE: Proteome Sciences Proposes New Placing; Revenues Rose 54 Percent in 2009 | GenomeWeb

The story has been revised to correct the name of the trading subsidiary on a loan. The correct name is Electrophoretics Limited. GenomeWeb Daily News regrets the error.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Proteome Sciences today separately announced a proposed placing, new offer, and preliminary results for full-year 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.